WPI 900 Pill - yellow round, 6mm
Pill with imprint WPI 900 is Yellow, Round and has been identified as Glipizide Extended Release 2.5 mg. It is supplied by Watson Pharmaceuticals.
Glipizide is used in the treatment of Diabetes, Type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WPI 900
Glipizide Extended Release
- Imprint
- WPI 900
- Strength
- 2.5 mg
- Color
- Yellow
- Size
- 6.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Sulfonylureas
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Pharmaceuticals
- Inactive Ingredients
-
acetyltributyl citrate,
ammonia,
butyl alcohol,
ferrosoferric oxide,
hydroxyethyl cellulose (2000 mpa.s at 1%),
isopropyl alcohol,
lactose monohydrate,
magnesium stearate,
methacrylic acid - methyl methacrylate copolymer (1:1),
polyethylene glycol 400,
propylene glycol,
shellac,
FD&C Yellow No. 6
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00591-0900 | Watson Pharmaceuticals, Inc. |
| 68084-0295 | Amerisource Health Services |
More about glipizide
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (69)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: sulfonylureas
- Breastfeeding
- En español
Patient resources
Other brands
Glucotrol, GlipiZIDE XL, Glucotrol XL
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.